EVER FORTUNE.AI, established in June 2018, has been committing to the innovation of medical big data and artificial intelligence, focusing on the applications of intelligent healthcare and precision medicine. Our vision is to become a leader in digital healthcare, aiming to improve the prevention, diagnosis, and treatment of diseases.
Since the establishment in 2018, EVER FORTUNE.AI has won 3 silver medals in world-class AI competitions and have been awarded the Taiwan National Innovation Award for 4 consecutive years. We have obtained 13 US FDA clearances, 16 Taiwan FDA clearances, 4 Vietnam medical device approvals, 5 Thailand medical device approvals as well as 28 patents worldwide.
Leveraging medical big data analysis, AI-assisted diagnostics, and cloud-based biomedical platforms, EFAI provides innovative AI-driven healthcare solutions across hospitals, pharmaceutical companies, medical aesthetics, biotechnology, and health management.
Everfortune.AI is ambitiously expanding from Taiwan to global.
We aggressively obtain more regulatory approvals from countries around the world.
By partnering with leading international companies, we expanding cross-domain network.
We become a digital healthcare leader through innovative digital technology and new business model.